Today: 11 June 2026
Fresnillo stock slides nearly 4% as silver cools — Citi target and Probe deal steps in focus
15 January 2026
1 min read

Fresnillo stock slides nearly 4% as silver cools — Citi target and Probe deal steps in focus

London, Jan 15, 2026, 09:12 GMT — Regular session

  • Fresnillo shares dip in early London trading after silver and gold retreat from their record peaks
  • Citi raises its Fresnillo price target to 4,600p and maintains a buy rating
  • Probe Gold shareholders have given the green light to Fresnillo’s takeover plan; the court hearing is scheduled for Jan. 19

Fresnillo (FRES.L) shares dipped on Thursday as silver prices slipped from their record highs, weighing on the London-listed miner. By 09:12 GMT, the stock had dropped 3.8% to 3,624 pence, down from Wednesday’s close of 3,766 pence.

Bullion pulled back after a strong rally. Spot silver dropped 3.4% to $89.63 an ounce, after hitting a record high of $93.57 earlier on Thursday. Gold slipped to $4,608.77 following a fresh peak the day before. Silver had cracked $90 for the first time on Wednesday. “Gold is down a bit … but the larger story is not going away,” said Ilya Spivak, head of global macro at Tastylive. (Safe-haven demand is investors buying gold for protection when markets feel unsettled.) Reuters

Fresnillo’s story is straightforward: with its heavy silver exposure, the stock acts as a quick gauge for traders’ expectations on price direction after recent volatility. The shares have swung sharply in response to changing rate-cut bets and geopolitical events.

Despite the market’s recent volatility, analysts remain upbeat. Citi bumped Fresnillo’s price target up to 4,600 pence from 4,000 and maintained its buy rating, TheFly reported.

Probe Gold confirmed its shareholders have approved a plan of arrangement, a court-supervised takeover mechanism in Canada, under which Fresnillo will buy Probe for C$3.65 a share. The company is set to return to an Ontario court on Jan. 19 for a final order, with closing anticipated on or about Jan. 21.

In October, Fresnillo struck a deal to acquire Probe for roughly C$780 million ($556 million) in cash, Reuters reported. The move accelerates Fresnillo’s North American expansion and adds the Novador gold project in Quebec to its portfolio. Fresnillo CEO Octavio Alvídrez said Probe’s assets would “meaningfully complement” the company’s development pipeline. Reuters

Near-term risks hinge on metal prices. A sharper drop in silver or gold could swiftly dent earnings forecasts. Meanwhile, the Probe deal remains subject to court approval and the standard closing hurdles.

London traders are eyeing whether bullion can hold steady after recent volatility and how U.S. data will shift interest-rate expectations—a crucial factor for gold, which doesn’t pay interest.

Investors have their eyes on Fresnillo’s Q4 2025 production report, set for release on Jan. 28. This update will reveal volumes and costs as the company moves into 2026.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
NASA pulls Crew-11 from ISS in first medical evacuation as SpaceX Dragon heads for splashdown
Previous Story

NASA pulls Crew-11 from ISS in first medical evacuation as SpaceX Dragon heads for splashdown

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls
Next Story

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls

Go toTop